The Author(s), under exclusive licence to Springer Nature America, Inc." Authors Victoria H Wu , Bryan S Yung , Farhoud Faraji , Robert Saddawi-Konefka , Zhiyong Wang , Alexander T Wenzel , Miranda J Song , Meghana S Pagadala , Lauren M Clubb , Joshua Chiou , Sanju Sinha , Marin Matic , Francesco Raimondi , Thomas S Hoang , Rebecca Berdeaux , Dario A A Vignali , Ramiro Iglesias-Bartolome

Bryan Roth About this episode Dr. Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Bryan leads a $26.9 Million project to create better psychiatric medications, among other things. Join me and learn more about Bryan and his work. Dr. Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

discussions with experts Provide researchers with a different outlet to make their work known and Inspire young Bryan Roth, Dr. Robert Lefkowitz, Dr. Fiona Marshall, Dr. Sam Hoare, Dr. Graciela Pineyro, Dr. Brian Kobilka, and many other amazing scientists.

GPCR Podcast << Back to podcast list Tanishka S. Saraf About Tanishka S. neurobiology of neuropsychiatric disorders and to develop safe and effective treatments. " Tanishka S.

Alexander S. Hauser About Dr. Alexander S. Alexander S.

Pandy-Szekeres September 13, 2021 at 2:00:00 PM Learn More >> CXCR4 heteromers as novel cancer targets Juan José Fung Phosphorylation Barcode as a Mechanism of Biased β-arrestin 2 Recruitment and Conformation at CXCR3 Dylan S. Brian Arey, Dr. Samuel Hoare, Dr. Ajay Yekkirala, Dr. Bryan Roth September 17, 2021 at 7:00:00 PM Learn More >> Nanobody tethering to dissect GPCR pharmacology

Bryan Roth at the same University.

Authors Carlos H Hiroki , Bryan G Yipp Source Contribute to the GPCR News Coming soon Become a Contributor

Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology

Bryan Roth (current) Dr. Ali Salahpour (2007) Dr. Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.

the beta2-adrenergic receptor (beta2AR)-G protein complex, team effort with long time collaborator Brian G protein splice forms, specifically the short and long forms of the stimulatory G protein, Galpha-s( s) and Galpha-s(l), respectively. We demonstrated that Galpha-s(l), but not Galpha-s(s), regulates extracellularly regulated kinases (ERK We speculate that these aberrations in Galpha-s(l), specifically, may be involved in other pathologies

Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. Fung continued his Postdoctoral training in Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.

The GAIN Domain Tobias Langenhan Characterization of Phenotypes Associated with GPR110 Deletion Hee-Yong Kim "Senior Investigator and Chief of the Laboratory of Molecular Signaling at NIAAA, NIH" Hee-Yong Additionally, the bacterium Vibrio fischeri also induces mating in S. rosetta cultures, suggesting that adhesion GPCR, named Cupidon, that regulates the switch from vegetative growth to sexual reproduction in S. Together, our results suggest that Cupidon prevents sexual reproduction in S. rosetta under high nutrient

GPCR Podcast << Back to podcast list Brian Shoichet About Dr. Brian Shoichet BSc in Chemistry from MIT, Ph.D. with Tack Kuntz at UCSF; Postdoc with Brian Matthews Brian Shoichet on the web Google Scholar Shoichet Lab Twitter Dr.

Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr.

Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr.

Brian Bender About Dr. Brian Bender Dr. Between undergraduate and graduate school Brian worked as a technician in an academic lab before moving Brian is involved in organizing the GRC/GRS Molecular Pharmacology meeting, which has been postponed Brian is one of the organizers of the upcoming Transatlantic ECI GPCR Symposium . Dr. Brian Bender on the web LinkedIn Twitter ResearchGate Dr.GPCR Member Google Scholar Dr.

Authors R Mishra, S K Biswas, S Nandi, S Mahajan, K G Sai Balaji, V Gairola, D Poloju, S Gulzar, K P

Chair Professor, Intermediate Fellow, Wellcome Trust DBT India Alliance Swarnajayanti Fellow & EMBO Young Brian Kolbika of Stanford University. Join us and learn more about Dr.

The percentage of cells in the S-M phase was decreased in MCF-7 cells treated with KS-133. MEK) inhibitor U0126 and the class I PI3K inhibitor ZSTK474 decreased the percentage of cells in the S KS-133 reduced the percentage of cells in the S phase more than treatment with U0126 or ZSTK474 alone regulates cyclin D1 levels through the cAMP/PKA/ERK and PI3K/AKT/GSK3β pathways, and mediates the G1/S

< GPCR News < GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for Here, we identify that A2aR is specifically expressed on tumor cells from lung adenocarcinoma (LUAD) Authors Ying Bai , Xin Zhang , Jiawei Zhou , Jianqiang Guo , Yafeng Liu , Chao Liang , Wenyang Wang , Tags A2aR , Lung adenocarcinoma , Migration , Polarization , Targeted therapy , Tumor-associated macrophages

promote cancer cell motility. " Authors Yu Jin Lee , Kyeong Jin Shin , Hyun-Jun Jang , Jin-Sun Ryu , Chae Young Lee , Jong Hyuk Yoon , Jeong Kon Seo , Sabin Park , Semin Lee , A Reum Je , Yang Hoon Huh , Sun-Young Kong , Taejoon Kwon , Pann-Ghill Suh , Young Chan Chae Tags GPR143 , HRS , MVB , breast cancer , exosomal

< GPCR News < GPCRs in Oncology and Immunology RGS20 promotes non-small cell lung carcinoma proliferation Background: Novel therapeutic targets are urgently needed for treating drug-resistant non-small cell lung Methods: Immunohistochemistry and lung cancer tissue microarray were used to verify the expression of the role of RGS20 as a promising novel molecular marker and a target for future targeted therapies in lung Li , Yanxia Jiang , Yujun Li , Hong Li , Lipeng Shang , Guilin Feng , Huhu Zhang , Ziyuan Xu , Lina Yang

Mrgpra1-NPFF axis counter-regulated interferon (IFN) γ-mediated neutrophil polarization during acute lung Authors Naina Gour , Hwan Mee Yong , Aishwarya Magesh , Aishwarya Atakkatan , Felipe Andrade , Stephane Lajoie , Xinzhong Dong Tags IFNγ , Mrgpra1 GPCR , NPFF , lung infection , neuropeptide FF , neutrophil

Halpern , Eduardo Rodríguez-Arbolí , Megan Othus , Kelsey-Leigh A Garcia , Mary-Elizabeth M Percival , Ryan D Cassaday , Vivian G Oehler , Pamela S Becker , Jacob S Appelbaum , Janis L Abkowitz , Johnnie J Orozco

Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation

Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation

Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation